International Health and Development Organisations: Roles and Partnerships

International health and development organisations form the core architecture of global public health governance, human development, and crisis response. Operating under multilateral treaties, public-private partnerships, and specialized mandates, these entities coordinate global health standards, finance large-scale disease eradication programs, and assist national governments in strengthening health systems. The landscape relies on structured collaborations between United Nations agencies, global financing facilities, philanthropic institutions, and bilateral aid channels to achieve Sustainable Development Goal 3 (Good Health and Well-Being) and related human development targets.

Primary Multilateral and United Nations Agencies

World Health Organization (WHO)
  • Status and Mandate: Established on April 7, 1948, as a specialized agency of the United Nations, headquartered in Geneva, Switzerland. It acts as the directing and coordinating authority on international health work.
  • Core Functions: Formulates evidence-based guidelines, sets international health regulations (IHR 2005), monitors global health trends, and manages public health emergencies of international concern (PHEIC).
  • Key Initiatives: Spearheaded the global eradication of smallpox (declared eradicated in 1980) and leads the Global Polio Eradication Initiative (GPEI) alongside Rotary International, CDC, UNICEF, and Gavi.
United Nations Children’s Fund (UNICEF)
  • Status and Mandate: Created in December 1946 by the UN General Assembly, headquartered in New York City, United States.
  • Core Functions: Focuses on maternal, newborn, and child health, child nutrition, routine immunization, and water, sanitation, and hygiene (WASH) infrastructure.
  • Procurement Operations: Serves as the largest global buyer of routine vaccines, procuring over two billion doses annually for low- and middle-income countries.
United Nations Development Programme (UNDP)
  • Status and Mandate: Established in November 1965, headquartered in New York City. It leads UN technical assistance and capacity-building efforts for sustainable human development.
  • Core Functions: Publishes the annual Human Development Report (introducing the Human Development Index in 1990). Supports countries in managing health implementation programs, particularly as an interim principal recipient for Global Fund grants in fragile states.
United Nations Population Fund (UNFPA)
  • Status and Mandate: Created in 1969, headquartered in New York City.
  • Core Functions: Leads global efforts in sexual and reproductive health, reduction of maternal mortality, voluntary family planning, and gender-based violence prevention.
World Bank Group (Health, Nutrition, and Population Division)
  • Status and Mandate: Provides long-term loans, credits, and grants to developing countries through the International Bank for Reconstruction and Development (IBRD) and International Development Association (IDA).
  • Core Functions: Finances health system strengthening, universal health coverage (UHC) programs, and hosts major health trust funds, including the Global Financing Facility (GFF) and the Pandemic Fund.

Hybrid Public-Private Partnerships and Global Funds

Gavi, the Vaccine Alliance
  • Structure: Launched in 2000 at the World Economic Forum, headquartered in Geneva, Switzerland. It combines public sectors (WHO, UNICEF, World Bank) with private entities (Bill & Melinda Gates Foundation, vaccine manufacturers, civil society).
  • Objective: Accelerates access to new and underused vaccines for children in low-income countries.
  • Market-Shaping Mechanisms: Uses Advance Market Commitments (AMC) to lower childhood vaccine prices and subsidizes national rollout plans.
The Global Fund to Fight AIDS, Tuberculosis and Malaria
  • Structure: Created in 2002, headquartered in Geneva, Switzerland. It functions as an independent, international financing institution.
  • Objective: Attracts and disburses financial resources to prevent and treat HIV/AIDS, tuberculosis, and malaria. It accounts for the majority of international funding dedicated to TB and malaria interventions globally.
Coalition for Epidemic Preparedness Innovations (CEPI)
  • Structure: Established in 2017 at Davos by the governments of Norway and India, the Bill & Melinda Gates Foundation, Wellcome Trust, and the World Economic Forum. Headquartered in Oslo, Norway.
  • Objective: Finances research and development for new vaccines against emerging infectious diseases (Disease X, Lassa fever, MERS, Ebola) and coordinates epidemic preparedness.
Unitaid
  • Structure: Founded in 2006 by Brazil, Chile, France, Norway, and the United Kingdom. Hosted by WHO in Geneva.
  • Objective: Uses innovative financing mechanisms, such as air ticket levies, to accelerate market entry and access for health technologies, diagnostic tests, and treatments for HIV, TB, malaria, and cervical cancer.

Comparative Overview of International Health Entities

Organisation / Partnership Type Headquarters Primary Focus Key Financing Mechanism
WHO UN Specialized Agency Geneva, Switzerland Health policy, norms, disease surveillance, PHEIC declarations Assessed and voluntary contributions from member states
UNICEF UN Programme New York, USA Child health, nutrition, routine immunization procurement Voluntary contributions from governments and donor bodies
Gavi, the Vaccine Alliance Public-Private Partnership Geneva, Switzerland Vaccine access in low-income nations, market shaping Donor pledges, International Finance Facility for Immunisation (IFFIm)
The Global Fund Financial Institution Geneva, Switzerland Grants for HIV/AIDS, TB, and Malaria prevention/treatment Multi-year replenishment conferences
CEPI Public-Private Foundation Oslo, Norway Epidemic vaccine research and platform technology development Public grants, philanthropic funding
Global Financing Facility (GFF) Trust Fund (World Bank) Washington, D.C., USA Reproductive, maternal, newborn, child, and adolescent health Blended finance matching IDA/IBRD co-financing

Strategic Partnerships and Operational Frameworks

The International Health Partnership (IHP+) / UHC2030

IHP+ transitioned into UHC2030 to build multi-stakeholder partnerships supporting progress toward Universal Health Coverage. It aligns international donor funding behind single, national health strategic plans designed by country governments, reducing duplication and administrative fragmentation.

Access to COVID-19 Tools Accelerator (ACT-A) and COVAX

Formed in April 2020 by WHO, the European Commission, France, and the Bill & Melinda Gates Foundation, ACT-A coordinated diagnostics, therapeutics, and health systems support. COVAX, the vaccine pillar co-led by CEPI, Gavi, and WHO alongside delivery partner UNICEF, distributed over 1.9 billion COVID-19 vaccine doses to 146 countries.

The Pandemic Fund

Established in September 2022 and hosted by the World Bank with technical support from WHO, the Pandemic Fund provides dedicated grants to low- and middle-income countries for critical capacities: disease surveillance, laboratory capacity, and health workforce preparedness.

Alliance for Health Policy and Systems Research

Hosted by WHO, this global collaboration promotes the generation and use of health policy and systems research (HPSR) to improve health systems operating in developing nations.

Key Facts for Quick Revision

  • World Health Day is observed globally on April 7, commemorating the establishment of the World Health Organization in 1948.
  • The International Health Regulations (IHR 2005) represent a legally binding international law instrument covering 196 countries to prevent global spread of diseases.
  • Smallpox remains the only human infectious disease officially declared completely eradicated by WHO (1980).
  • Rinderpest was declared eradicated in 2011 by the FAO and WOAH, making it the second animal disease eradicated globally.
  • The Human Development Index (HDI) was introduced by Mahbub ul Haq and Amartya Sen under UNDP in 1990.
  • Gavi was established in 2000, and its International Finance Facility for Immunisation (IFFIm) uses long-term government pledges to issue vaccine bonds in capital markets.
  • The Global Fund provides approximately 30% of all international financing for HIV programs, 76% for tuberculosis, and 63% for malaria.
  • CEPI aims to shorten the timeline to develop new vaccines against emerging threats to 100 days under its 100-Day Mission.
  • The Pandemic Fund was created under World Bank financial hosting in September 2022 to fill structural gaps in pandemic prevention and response.
  • UNICEF manages procurement of vaccines that protect over 45% of the world’s children under five years of age.
Originally written on December 4, 2015 and last modified on August 13, 2026.

Leave a Reply

Your email address will not be published. Required fields are marked *